Lewis Asset Management’s Avalyn Pharma AVLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$228K Buy
+8,000
New +$258K 0.08% 200

Other funds holding AVLN

Lewis Asset Management's AVLN Position: Q3 2026 in Review

Lewis Asset Management opened a new position in Avalyn Pharma (AVLN) in Q3 2026: 8,000 shares worth $228K. The stake represents 0.08% of the portfolio and ranks #200 among its holdings.

116 funds tracked by Wall St. Rank hold AVLN as of Q3 2026.

  • Lewis Asset Management held 8,000 shares of Avalyn Pharma worth $228K as of Q3 2026.
  • Avalyn Pharma was a new Lewis Asset Management position in Q3 2026.
  • Avalyn Pharma made up 0.08% of Lewis Asset Management's portfolio in Q3 2026, its #200 holding.
  • 116 funds tracked by Wall St. Rank held Avalyn Pharma as of Q3 2026.

Based on Lewis Asset Management's 13F filing for Q3 2026, filed 14 Oct 2026.